로딩 중…
StockDiggingStockDigging

Alexandria Real Estate Equities, Inc.

ARE· NYSE
$51.02+3.68%
2026-06-18

Price Chart

Alexandria Real Estate Equities, Inc.-24.44%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$8.89B
Revenue$2.90B
Net Income$-1.02B
Total Assets$34.17B
Net Assets$15.73B
Employees514
Value
P/B0.57x
P/S3.07x
EV/EBITDA52.64x
FCF Yield15.78%
Profitability
ROE-6.50%
ROA-2.99%
Op. Margin-42.76%
Revenue Growth-9.71%
Earnings Growth-542.96%
Financial Health
Debt Ratio94.09%
Total Debt$12.88B
FCF$1.40B
Cash$419M
Current Ratio0.29x
Net Debt/EBITDA30.72x
Dividend
Div. Yield9.06%
Div. Growth2.43%
Performance
1Y Return-24.44%
1M Return11.30%
From 52W High-40.39%
1Y MDD-52.36%
Trading
Volume787,616 shares
Trading Value$40M
Per Share
EPS$-8.40
BPS$90.79

Company Info

CEO Mr. Peter M. Moglia
Employees 514
HQ Pasadena, United States

Alexandria Real Estate Equities, Inc. an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Mega campus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of December 31, 2025, Alexandria has a total market capitalization of $20.75 billion and an asset base in North America that includes 35.9 million RSF of operating properties and 3.5 million RSF of Class A/A+ properties undergoing construction. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Mega campus environments that enhance our tenant ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.